Related Experiment Video
Updated: Jun 25, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Regulatory T cells in bronchial asthma
K Ryanna1, V Stratigou, N Safinia
1MRC and Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, UK.
Allergy
|February 18, 2009
Summary
Regulatory T cells (Tregs) play a crucial role in asthma. Impaired Treg function is linked to asthma development, while therapies that restore Treg activity show therapeutic potential for managing allergic and asthmatic diseases.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- Regulatory T cells (Tregs) are critical for immune homeostasis.
- Impaired Treg activity is implicated in the pathogenesis of bronchial asthma.
- Understanding Treg function is key to developing novel asthma therapies.
Purpose of the Study:
- To review the role of Tregs in the pathogenesis of bronchial asthma.
- To explore the therapeutic potential of Tregs in asthma treatment.
- To discuss strategies for enhancing Treg function in asthma.
Main Methods:
- Literature review of studies on Tregs and bronchial asthma.
- Analysis of evidence linking Treg function to asthma pathogenesis.
- Examination of therapeutic interventions affecting Treg activity.
Main Results:
- Tregs are essential for immune balance and exhibit reduced function in active asthma.
- Effective asthma therapies, such as glucocorticoids and allergen immunotherapy, are associated with Treg induction or restoration.
- Targeting Tregs offers a promising avenue for asthma treatment.
Conclusions:
- Restoring or enhancing Treg function is a viable therapeutic strategy for bronchial asthma.
- Further research into Treg-modulating therapies could improve asthma management.
- Optimizing Treg-based treatments is crucial for enhancing safety and efficacy.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...